BACKGROUND: Despite corticosteroid treatment, patients with temporal arteritis may continue to lose vision. However, predictors of progressive visual loss are not known. METHODS: We retrospectively reviewed 341 consecutive patients with suspected temporal arteritis who underwent temporal artery biopsy. 90 patients with biopsy proven temporal arteritis were included in our study. RESULTS: Twenty-one patients (23%) experienced continuous visual symptoms despite steroid therapy and 14 among these suffered persistent visual deterioration. Based on univariate analysis, visual loss on presentation was associated with disc swelling and a history of hypertension. Risk factors for progressive visual loss included older age, elevated C reactive protein and disc swelling. CONCLUSION: Although corticosteroid therapy improves the visual prognosis in temporal arteritis, steroids may not stop the progression of visual loss. Our study reliably establishes the risk factors for visual loss in this serious condition. Whether addressing these risk factors early in their presentation can alter the visual outcome remains unknown. Individual risk anticipating treatment regimens and strategies might improve the visual prognosis in temporal arteritis in the future.
BACKGROUND: Despite corticosteroid treatment, patients with temporal arteritis may continue to lose vision. However, predictors of progressive visual loss are not known. METHODS: We retrospectively reviewed 341 consecutive patients with suspected temporal arteritis who underwent temporal artery biopsy. 90 patients with biopsy proven temporal arteritis were included in our study. RESULTS: Twenty-one patients (23%) experienced continuous visual symptoms despite steroid therapy and 14 among these suffered persistent visual deterioration. Based on univariate analysis, visual loss on presentation was associated with disc swelling and a history of hypertension. Risk factors for progressive visual loss included older age, elevated C reactive protein and disc swelling. CONCLUSION: Although corticosteroid therapy improves the visual prognosis in temporal arteritis, steroids may not stop the progression of visual loss. Our study reliably establishes the risk factors for visual loss in this serious condition. Whether addressing these risk factors early in their presentation can alter the visual outcome remains unknown. Individual risk anticipating treatment regimens and strategies might improve the visual prognosis in temporal arteritis in the future.
Authors: Aileen A Antonio-Santos; Sally J Murad-Kejbou; Rod Foroozan; Sunita Yedavally; David I Kaufman; Eric R Eggenberger Journal: J Vasc Interv Neurol Date: 2016-01
Authors: Gunnar Tomasson; Christine Peloquin; Aladdin Mohammad; Thorvardur J Love; Yuqing Zhang; Hyon K Choi; Peter A Merkel Journal: Ann Intern Med Date: 2014-01-21 Impact factor: 25.391
Authors: James A Prior; Hoda Ranjbar; John Belcher; Sarah L Mackie; Toby Helliwell; Jennifer Liddle; Christian D Mallen Journal: BMC Med Date: 2017-06-28 Impact factor: 8.775
Authors: Max Yates; Karly Graham; Richard Arthur Watts; Alexander James MacGregor Journal: BMC Musculoskelet Disord Date: 2016-07-15 Impact factor: 2.362